Esophageal cancer
Therapeutic area
Gastroenterology
Rare disease
No
- Definition
- A primary or metastatic malignant neoplasm involving the esophagus.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Esophageal cancer
- Therapeutic area
- Gastroenterology
- esophageal cancer
- cancer of esophagus
- cancer of oesophagus
- esophageal cancer
- esophageal cancer, somatic
- esophageal carcinoma, somatic
- esophageal squamous cell carcinoma, somatic
- esophagus cancer
- malignant esophageal neoplasm
- malignant esophageal tumor
- malignant esophageal tumour
- malignant esophagus neoplasm
- malignant esophagus tumor
- malignant neoplasm of esophagus
- malignant neoplasm of oesophagus
- malignant neoplasm of the esophagus
- malignant neoplasm of the oesophagus
- malignant oesophagus neoplasm
- malignant oesophagus tumour
- malignant tumor of esophagus
- malignant tumor of the esophagus
- malignant tumour of oesophagus
- malignant tumour of the oesophagus
- oesophagus cancer
- Ca lower third esophagus
And 21 more, listed on the interactive page.
- Severity
- Severe
- Gastroenterology
- Oncology
- MONDO ID
- MONDO:0007576
- Parent condition
- MONDO:0002516
Related records
Broader conditions (14)
- Cancer
- Cancer or benign tumor
- Digestive system cancer
- Digestive system disorder
- Digestive system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Esophageal disorder
- Human disease
- Neoplasm
- Neoplasm of esophagus
- Neoplastic disease or syndrome
- Upper digestive tract disorder
Narrower conditions (21)
- Barrett adenocarcinoma
- Carcinoma of esophagus
- Carcinoma of esophagus, salivary gland type
- Esophageal adenocarcinoma
- Esophageal adenoid cystic carcinoma
- Esophageal adenosquamous carcinoma
- Esophageal basaloid carcinoma
- Esophageal melanoma
- Esophageal small cell neuroendocrine carcinoma
- Esophageal squamous cell carcinoma
- Esophagus carcinoma in situ
- Esophagus leiomyosarcoma
- Esophagus liposarcoma
- Esophagus lymphoma
- Esophagus sarcoma
- Esophagus verrucous carcinoma
- Malignant neoplasm of abdominal esophagus
- Malignant neoplasm of cervical esophagus
- Malignant neoplasm of thoracic esophagus
- Mucoepidermoid esophageal carcinoma
Trials (1,332)
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
- 18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
- 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
- 4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies
- 4D FDG PET in Esophageal Cancer
- 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- 99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma
- 99mTc-3PRGD2 SPECT/CT in Esophagus Cancer Patients
- A Beta-only IL-2 ImmunoTherapY Study
- A Biomarker-driven Therapeutic Strategy for Esophageal Cancer Chemoradiotherapy in Patients With Resectable Adenocarcinoma of the ESophagus and Esophagogastric Junction
- A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer
- A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma
- A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
- A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer
- A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
- A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
Approved drugs (1)
Drugs in development (126)
- 9-aminocamptothecin Phase 2
- Adebrelimab Phase 2
- Agatolimod sodium Phase 1
- Alvocidib Phase 2
- AMG-337 Phase 1
- Armodafinil Phase 2
- Arsenic trioxide Phase 2
- Aspirin Phase 3
- Atezolizumab Phase 3
- Azacitidine Phase 1
- Bemarituzumab Phase 1
- Bevacizumab Phase 2
- Buparlisib Phase 2
- Cadonilimab Phase 2
- Caffeic acid Phase 3
- Calcium gluconate Phase 1
- Camrelizumab Phase 3
- Capecitabine Phase 3
- Carboplatin Phase 3
- Catequentinib Phase 2
Other linked drugs (2)
- Sivelestat sodium
- Sorafenib